Strategies to modulate the immune system in breast cancer: checkpoint inhibitors and beyond

Is breast cancer (BC) immunogenic? Many data suggest that it is. Many observations demonstrated the prognostic role of tumor-infiltrating lymphocytes (TILs) in triple negative (TN) and human epidermal growth factor receptor 2 (HER-2)-positive BC. TNBCs are poorly differentiated tumors with high gene...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ther Adv Med Oncol
Autors principals: Migali, Cristina, Milano, Monica, Trapani, Dario, Criscitiello, Carmen, Esposito, Angela, Locatelli, Marzia, Minchella, Ida, Curigliano, Giuseppe
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2016
Matèries:
Reviews
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4981297/
https://ncbi.nlm.nih.gov/pubmed/27583028
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834016658423
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars